For the P&T Operating Procedures, and our Quality Assessment Tool and evidence grading methods, please visit our Policies and Procedures page.
The policy on public comment during meetings can be read at this page.
The Oregon P & T Committee is comprised of a 11-member volunteer, advisory committee of physicians, pharmacists and consumer representatives. The committee, established in compliance with the Omnibus Budget Reconciliation Act of 1990 (OBRA '90), is responsible for performing drug use review and making drug policy recommendations for OMAP.
The goals of the committee are to:
If interested in serving on the P & T Committee in the future or providing public testimony at Committee meetings, contact: Roger Citron at 503-947-5220 or by email: roger.a.citron @ state.or.us
You may also elect to receive notifications by email of meeting schedules, document postings and newsletters by subscribing to the OSUPHARMDI list-serv.
For specific meeting information, including upcoming dates and meeting materials, please click here.